Variant report

Variant	nsv1032096
Chromosome Location	chr6:26698728-26783655
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:3)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:26757504..26759544-chr6:26759829..26761345,2	K562	blood:
2	chr6:26569878..26572045-chr6:26757682..26759933,2	K562	blood:
3	chr6:26757504..26759544-chr6:26759829..26761345,2	K562	blood:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ABT1-4	chr6:26728058-26728148	XLOC_005215
2	lnc-ABT1-4	chr6:26752185-26752237	XLOC_005215
3	lnc-ABT1-6	chr6:26712863-26714864	ucscGeneNc_uc010jqm_1
4	lnc-ABT1-4	chr6:26724185-26724429	XLOC_005215
5	lnc-ABT1-6	chr6:26710940-26711798	ucscGeneNc_uc010jqm_1

No data

Extended variants
information (count: 1701 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:1701 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs568486644	chr6:26698728-26698729	Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs563589475	chr6:26698731-26698732	Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs573851540	chr6:26698735-26698736	Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs542819117	chr6:26698767-26698768	Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs372787016	chr6:26698854-26698855	Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs559618242	chr6:26698859-26698860	Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs528163057	chr6:26698942-26698943	Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs372841570	chr6:26698968-26698969	Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs551499201	chr6:26699028-26699029	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs564687681	chr6:26699045-26699046	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs530544924	chr6:26699046-26699047	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs373692769	chr6:26699052-26699053	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs199925467	chr6:26699057-26699058	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs567600734	chr6:26699072-26699073	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs536583239	chr6:26699121-26699122	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs546782024	chr6:26699148-26699149	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs567102543	chr6:26699198-26699199	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs539424101	chr6:26699233-26699234	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs559018671	chr6:26699340-26699341	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs575515030	chr6:26699353-26699354	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs368652396	chr6:26699359-26699360	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs538264829	chr6:26699423-26699424	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs557529333	chr6:26699432-26699433	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs368990826	chr6:26699463-26699464	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs542980599	chr6:26699496-26699497	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs559277392	chr6:26699534-26699535	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs572995457	chr6:26699539-26699540	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs544745389	chr6:26699552-26699553	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs375547324	chr6:26699675-26699676	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs530549995	chr6:26699677-26699678	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs550147734	chr6:26699745-26699746	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs560591393	chr6:26699780-26699781	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs368238811	chr6:26699850-26699851	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs530325453	chr6:26699857-26699858	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs546894457	chr6:26699895-26699896	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs572886051	chr6:26699911-26699912	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs566911145	chr6:26699955-26699956	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs533697870	chr6:26699989-26699990	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs539236248	chr6:26700002-26700003	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs561260164	chr6:26700034-26700035	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs556179252	chr6:26700036-26700037	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs35219740	chr6:26700042-26700043	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs56146942	chr6:26700052-26700053	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs9467840	chr6:26700053-26700054	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs192079194	chr6:26700072-26700073	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs555579460	chr6:26700111-26700112	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs552361090	chr6:26700128-26700129	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs569312734	chr6:26700179-26700180	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs573915288	chr6:26700198-26700199	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs538373358	chr6:26700210-26700211	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Williams-beuren syndrome	16971481	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	21569311	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:503 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26697600-26699000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
2	chr6:26698000-26698800	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
3	chr6:26698000-26698800	Bivalent/Poised TSS	NHEK	skin
4	chr6:26698200-26698800	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
5	chr6:26698200-26698800	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr6:26698200-26698800	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr6:26698200-26698800	Bivalent/Poised TSS	NHDF-Ad	bronchial
8	chr6:26698400-26698800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr6:26698400-26698800	Enhancers	HMEC	breast
10	chr6:26698400-26701400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr6:26698600-26698800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr6:26698600-26698800	Flanking Active TSS	H9 Cell Line	embryonic stem cell
13	chr6:26698600-26698800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr6:26698600-26698800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
15	chr6:26698600-26698800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
16	chr6:26698600-26698800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
17	chr6:26698600-26698800	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr6:26698600-26698800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
19	chr6:26698600-26698800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
20	chr6:26698600-26698800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr6:26698600-26698800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr6:26698600-26698800	Bivalent Enhancer	Brain Cingulate Gyrus	brain
23	chr6:26698600-26698800	Bivalent Enhancer	Brain Hippocampus Middle	brain
24	chr6:26698600-26698800	Enhancers	K562	blood
25	chr6:26698600-26699000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
26	chr6:26698600-26699000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
27	chr6:26698800-26699000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
28	chr6:26698800-26699000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
29	chr6:26698800-26701000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr6:26698800-26701200	Weak transcription	H9 Cell Line	embryonic stem cell
31	chr6:26698800-26701400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr6:26698800-26701400	Weak transcription	HMEC	breast
33	chr6:26701000-26701200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
34	chr6:26701000-26701200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
35	chr6:26701000-26701200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
36	chr6:26701000-26701200	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
37	chr6:26701000-26701200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
38	chr6:26701000-26701200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
39	chr6:26701000-26701400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr6:26701000-26701400	Active TSS	K562	blood
41	chr6:26701000-26701800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr6:26701000-26702000	Active TSS	H1 Cell Line	embryonic stem cell
43	chr6:26701000-26702000	Active TSS	HUES48 Cell Line	embryonic stem cell
44	chr6:26701200-26701400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr6:26701200-26701400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
46	chr6:26701200-26701800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
47	chr6:26701200-26701800	Active TSS	iPS-18 Cell Line	embryonic stem cell
48	chr6:26701200-26702000	Active TSS	H9 Cell Line	embryonic stem cell
49	chr6:26701200-26702000	Active TSS	HUES6 Cell Line	embryonic stem cell
50	chr6:26701200-26702000	Active TSS	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links